Publishing research using ab47624? Please let us know so that we can cite the reference in this datasheet.

ab47624 has been referenced in 1 publication.

  • Bryant C  et al. Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers. BMC Cancer 14:570 (2014). WB . PubMed: 25104095

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"